Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy

Published:2021-12-15 Issue:12 Volume:13 Page:2161-2179
ISSN:1948-5204
Container-title:World Journal of Gastrointestinal Oncology
language:
Short-container-title:WJGO

Author:

Liu Zi-Ning,Wang Yin-Kui,Zhang Li,Jia Yong-Ning,Fei Shan,Ying Xiang-Ji,Zhang Yan,Li Shuang-Xi,Sun Yu,Li Zi-Yu,Ji Jia-Fu

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,Oncology

Reference37 articles.

1. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

2. Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

3. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer

4. Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey

5. Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Oncological Outcomes and Long-Term Survival among Patients with Gastric Cancer and Limited Peritoneal Disease Progression after Neoadjuvant Chemotherapy;Journal of Clinical Medicine;2023-12-27

2. Imaging lymph node regression can predict the pathological tumor regression grade in gastric cancer after neoadjuvant treatment;Surgery;2023-10

3. Immunosuppressive MFAP2+ cancer associated fibroblasts conferred unfavorable prognosis and therapeutic resistance in gastric cancer;Cellular Oncology;2023-08-04

4. Comparison of the predictive value of pathological response at primary tumor and lymph node status after neoadjuvant chemotherapy in locally advanced gastric cancer;Clinical and Translational Oncology;2023-04-24

5. Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations;Cancers;2023-01-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3